Literature DB >> 25680526

Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study.

Reza Mohebi1, Amirali Simforoosh1, Maryam Tohidi1, Fereidoun Azizi2, Farzad Hadaegh3.   

Abstract

OBJECTIVE: To evaluate the effect of different fat distribution measures on the risk of all-cause mortality events among chronic kidney disease (CKD) patients, which has not been previously evaluated.
METHODS: The present study consisted of 1,860 individuals with CKD, aged ≥30 years who participated in Tehran Lipid and Glucose Study. The estimated glomerular filtration rate was estimated using the abbreviated prediction equation, provided by the Modification of Diet in Renal Disease formula, and CKD was defined as estimated glomerular filtration rate < 60 mL/minute/1.73 m2. Cox proportional hazard regression was implemented to estimate the hazard ratios (HRs) of different anthropometric measures for predicting mortality events.
RESULTS: During 10.1 years of follow-up, 221 cases of all-cause mortality events occurred. In confounder-adjusted model (age, sex, creatinine, the history of cardiovascular disease, and smoking), none of the HRs of different anthropometric measures reached the significant level; however, when we also considered mediator variables (hypertension, diabetes, and hypercholesterolemia) in the model, there was significant interaction between sex and waist circumference for the risk prediction of mortality events. Among men, the HRs of mortality for 1 standard deviation increase in anthropometric measures were 0.73 (0.57-0.92) for weight, 0.67 (0.54-0.83) for waist circumference, 0.75 (0.58-0.97) for body mass index, and 0.71 (0.52-0.96) for hip circumference. However among women, none of the measures were associated with increased risk of all-cause mortality events.
CONCLUSION: Among men with CKD, regardless of fat distribution in hip, waist, or in whole body, having more fat mass results in better survival.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680526     DOI: 10.1053/j.jrn.2014.12.006

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  10 in total

1.  Editor's Spotlight/Take 5: Body Mass Index is Associated with All-cause Mortality After THA and TKA.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2018-06       Impact factor: 4.176

2.  Obesity is associated with insulin resistance but not skeletal muscle dysfunction or all-cause mortality.

Authors:  Jeremy P Loenneke; Paul D Loprinzi
Journal:  Age (Dordr)       Date:  2015-12-24

3.  Fat Mass Is Associated With Cystatin C and Estimated Glomerular Filtration Rate in Adolescents With Type 1 Diabetes.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  J Ren Nutr       Date:  2015-05-29       Impact factor: 3.655

4.  Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service.

Authors:  Emma Davis; Katrina Campbell; Glenda Gobe; Carmel Hawley; Nicole Isbel; David W Johnson
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

Review 5.  Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review.

Authors:  Wengen Zhu; Rong Wan; Fuwei Liu; Jinzhu Hu; Lin Huang; Juxiang Li; Kui Hong
Journal:  J Am Heart Assoc       Date:  2016-09-09       Impact factor: 5.501

6.  Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness.

Authors:  Chloë Goossens; Mirna Bastos Marques; Sarah Derde; Sarah Vander Perre; Thomas Dufour; Steven E Thiessen; Fabian Güiza; Thomas Janssens; Greet Hermans; Ilse Vanhorebeek; Katrien De Bock; Greet Van den Berghe; Lies Langouche
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-07-20       Impact factor: 12.910

Review 7.  Recent Progress on Lipid Intake and Chronic Kidney Disease.

Authors:  Ke Pei; Ting Gui; Chao Li; Qian Zhang; Huichao Feng; Yunlun Li; Jibiao Wu; Zhibo Gai
Journal:  Biomed Res Int       Date:  2020-04-24       Impact factor: 3.411

8.  Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.

Authors:  Vicente Bertomeu-Gonzalez; José Moreno-Arribas; María Asunción Esteve-Pastor; Inmaculada Roldán-Rabadán; Javier Muñiz; Paula Raña-Míguez; Martín Ruiz-Ortiz; Ángel Cequier; Vicente Bertomeu-Martínez; Lina Badimón; Manuel Anguita; Gregory Y H Lip; Francisco Marín
Journal:  J Am Heart Assoc       Date:  2019-12-24       Impact factor: 5.501

9.  Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model.

Authors:  Jia Li; Gyorgy Simon; M Regina Castro; Vipin Kumar; Michael S Steinbach; Pedro J Caraballo
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.752

10.  The Association Between Body Mass Index and All-Cause Mortality in Patients With Type 2 Diabetes Mellitus: A 5.5-Year Prospective Analysis.

Authors:  Jeng-Fu Kuo; Yi-Ting Hsieh; I-Chieh Mao; Shi-Dou Lin; Shih-Te Tu; Ming-Chia Hsieh
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.